Meridian Bioscience
Losses Deep and Widespread as GenomeWeb Top 40 Drops 34 Percent in 2022
All but two Top 40 companies declined, with over half losing more than 50 percent of their value and 13 companies losing three-quarters of their value or more.
Meridian Bioscience Fiscal Q4 Revenues Fall 14 Percent, Full-Year Revenues Grow 5 Percent
The firm's diagnostics segment revenues climbed 14 percent year over year in fiscal Q4, while life sciences revenues were down 37 percent.
Meridian Bioscience Fiscal Q3 Revenues Rise 7 Percent as Acquisition Looms
The company's diagnostics revenues rose 36 percent, while life sciences revenues fell 21 percent.
FDA Reissues EUA for Meridian Bioscience COVID-19 Test After Omicron Variant Trouble
The test, which received Emergency Use Authorization from US regulators in late 2021, had to be updated in order to detect the variant.
SD Biosensor, SJL Partners to Acquire Meridian Bioscience for $1.5B
Meridian also announced preliminary results for its fiscal third quarter, expecting revenues between $66 million and $69 million.